|
|
| ¹«·á À̸ÞÀÏ @cell-signaling °èÁ¤ ¸¸µé±â |
|
|
Designed
by Heidi-Dream |
|
|
|
´ë»çÁõÈıº ¹× ¼¼Æ÷ ½ÅÈ£Àü´Þ ¿¬±¸½Ç (Matabolic Syndrome and Cell Signaling Laboratory)
|
|
|
|
|
| ¡á Home > °øÁö»çÇ× |

 |
| ¹Ú·æÁø ÇлýÀÇ 2¹øÂ° LETM1 paper°¡ Cancer Research¿¡ äÅõǾú½À´Ï´Ù ÃàÇÏÇÕ´Ï´Ù |
cell
| 02-12 |
| |
|
From: kyle.overturf@aacr.org [mailto:kyle.overturf@aacr.org]
Sent: Monday, February 09, 2009 2:16 PM
To: insulin@cnu.ac.kr
Subject: CANCER RESEARCH CAN-08-3235R1 -- Decision Rendered
Re: CAN-08-3235R1
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death in HeLa cells
Dear Dr. Park:
I am pleased to inform you that your CANCER RESEARCH manuscript CAN-08-3235R1,
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death in HeLa cells, has been accepted for publication in CANCER RESEARCH.
The scheduled publication date of your article will be provided on your proofs, which you will receive page proofs within 4 to 5 weeks. If you expect your address to change within that time, please inform us immediately by contacting the Editorial Office either via e-mail to cancerres@aacr.org, or via fax to (215)440-9354. If your manuscript submission information included an e-mail address, you will receive electronic page proofs. If you do not have access to e-mail, you will receive hard copy page proofs.
Please note that the assignment to which section of the journal your article will appear is made at the discretion of the editors.
Thank you in advance for your cooperation.
Sincerely,
Carl-Henrik Heldin, Ph.D.
Senior Editor
|
|
|
| |
|
|
|
Matabolic Syndrome and Cell Signaling Laboratory in Institute for Cancer Research Department of Pharmacology, College of Medicine, Chungnam National University
266 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea Tel: +82-42-280-6768 Fax: +82-42-585-6627 COPYRIGHT ¨Ï 2009 Metabolic Syndrome and Cell Signaling Laboratory, ALL RIGHTS RESERVED.
|
|
|